What is Citius Oncology, Inc.'s total revenue?

Citius Oncology, Inc. (CTOR) reported total revenue of $1.67M in Q1 2026.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Citius Oncology, Inc. CTOR Total Revenue

Total Revenue at other companies

Merck & Co.MRK

$16.29B+4.9%

Delcath SystemsDCTH

$24.99M+26.3%

Iovance Biotherapeutics, Inc.IOVA

$71.43M+44.8%

ImmunomeIMNM

$0-100%

Arcus BiosciencesRCUS

$17M-39.3%

ImmunityBio, Inc.IBRX

$44.21M+168%

Other financials

Income statement

See full

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s total revenue?: Citius Oncology, Inc. (CTOR) reported total revenue of $1.67M in Q1 2026.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.